Emerging role of FDG-PET for optimal response assessment in infectious diseases and disorders

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 2, 2011, Pages 143-145

  Basu, Sandip ^a   Alavi, Abass ^b  

^a TATA MEMORIAL HOSPITAL   (India)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

infection; PET; positron emission tomography; response

Indexed keywords

BENZIMIDAZOLE; FLUORODEOXYGLUCOSE F 18; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIATION MONITORING; TREATMENT DURATION; TREATMENT RESPONSE;

COMMUNICABLE DISEASES; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 79952148415     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.167     Document Type: Editorial

References (14)

1. Ozsahin H, von Planta M, Muller I et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 92, 2719-2724 (1998).
2. 18F-fluorodeoxyglucose imaging study in soft tissue infections in rats. Nucl. Med. Biol. 31, 875-882 (2004).
3. Bleeker-Rovers CP, de Sevaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am. J. Kidney. Dis. 41, E18-E21 (2003).
4. 18F-fluorodeoxyglucose positron emission tomography. Clin. Microbiol. Infect. 11, 493-495 (2005).
5. Win Z, Todd J, Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin. Nucl. Med. 30, 690-691 (2005).
6. Stumpe KD, Renner-Schneiter EC, Kuenzle AK et al. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 35(1), 11-18 (2007).
7. Win Z, O'Flynn E, O'Rourke EJ et al. F-18 FDG PET in the diagnosis and monitoring of salmonella vertebral osteomyelitis: a comparison with MRI. Clin. Nucl. Med. 31(7), 437-440 (2006).
8. Choi SJ, Lee JS, Cheong MH, Byun SS, Hyun IY. F-18 FDG PET/CT in the management of infected abdominal aortic aneurysm due to Salmonella. Clin. Nucl. Med. 33(7), 492-495 (2008).
9. Spacek M, Stadler P, Bělohlávek O, Sebesta P. Contribution to FDG-PET/CT diagnostics and post-operative monitoring of patients with mycotic aneurysm of the thoracic aorta. Acta Chir. Belg. 110(1), 106-108 (2010).
10. Doycheva D, Deuter C, Hetzel J et al. The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis. Br. J. Ophthalmol. DOI: 10.1136/ bjo.2010.182659 (2010) (Epub ahead of print).
11. Hofmeyr A, Lau WF, Slavin MA. Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography fordiagnosis and monitoring treatment response. Tuberculosis (Edinb.) 87(5), 459-463 (2007).
12. Liu L, Xu Y, Shea C, Fowler JS, Hooker JM, Tonge PJ. Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin andpyrazinamide in baboons. J. Med. Chem. 53(7), 2882-2891 (2010).
13. 18F- fluorodeoxyglucose positron emission tomography. Clin. Microbiol. Rev. 21(1), 209-224 (2008).
14. Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin. Nucl. Med. 39(1), 36-51 (2009).